IFN-γ/TNF-α ratio in response to immuno proteomically identified human T-cell antigens of Mycobacterium tuberculosis – The most suitable surrogate biomarker for latent TB infection-Reference-Cited by-同舟云学术

IFN-γ/TNF-α ratio in response to immuno proteomically identified human T-cell antigens of Mycobacterium tuberculosis – The most suitable surrogate biomarker for latent TB infection

Published:2015-08 Issue:2 Volume:71 Page:238-249
ISSN:0163-4453
Container-title:Journal of Infection
language:en
Short-container-title:Journal of Infection

Author:

Prabhavathi Maddineni,Pathakumari Balaji,Raja Alamelu

Publisher

Elsevier BV

Subject

Infectious Diseases,Microbiology (medical)

Reference51 articles.

1. Global tuberculosis control- surveillance, planning, Financing;World Health Organization (WHO),2014

2. Systematic review: T-cell-based assays for the diagnosis of latent tuberculosis infection: an update;Pai;Ann Intern Med,2008

3. Contacts of cases of active pulmonary tuberculosis;Grzybowski;Bull Int Union Tuberc,1975

4. Consensus statement. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country.WHO global surveillance and monitoring project;Dye;JAMA,1999

5. Priorities for the treatment of latent tuberculosis infection in the United States;Horsburgh;N Engl J Med,2004

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Gene Regulatory Mechanism of Mycobacterium Tuberculosis during Dormancy;Current Issues in Molecular Biology;2024-06-11

2. Construction of novel multi-epitope-based diagnostic biomarker HP16118P and its application in the differential diagnosis of Mycobacterium tuberculosis latent infection;Molecular Biomedicine;2024-04-29

3. Design and development of a multi‐epitope vaccine for the prevention of latent tuberculosis infection;Medicine Advances;2023-11-14

4. Nanoadjuvants Produced by Advanced Nanochelating Technology in the Inactivated-Severe Acute Respiratory Syndrome Coronavirus-2 Vaccine Formulation: Preliminary Results on Cytokines and IgG Responses;Viral Immunology;2023-08-01

5. Challenges and the Way forward in Diagnosis and Treatment of Tuberculosis Infection;Tropical Medicine and Infectious Disease;2023-01-28